DiscoverBeginner's Mind
Beginner's Mind
Claim Ownership

Beginner's Mind

Author: Christian Soschner

Subscribed: 2Played: 51
Share

Description

Beginner's Mind with Christian Soschner is a show about breakthrough innovators, entrepreneurs, investors, thought leaders, and the stories behind their success. Christian Soschner invites the listeners to learn with him from the best and brightest minds behind disruptive businesses, innovative investments, prolific social movements, and technologies powering game-changing innovation. In intimate conversations, the host deconstructs the stories to help turn their wisdom into practical tactics you can use to improve your life, grow your business and help your community. Join the LSG2G Community: https://lsg2g.substack.com/
109 Episodes
Reverse
Are you curious about what it takes to be a female venture capitalist in 2023? Join us as we sit down with Jeevan, a successful woman in the industry, to discuss the world of female entrepreneurship and venture capitalism. With her insights on the tech focus areas of 2023, the challenges of attracting women into the VC world, and the importance of warm referrals, Jeevan offers a unique perspective on the startup investment landscape. Get a glimpse into the life of a female VC as she shares her journey and valuable lessons learned. Tune in now to learn what it takes to become a venture capitalist in 2023 and expand your knowledge on the exciting world of startup investments.💡 LINKS TO MORE CONTENTIf you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Check out our partners: https://linktr.ee/lsg2Watch on YoutubeJeevan SunnerChristian Soschner📖 Memorable quotes:(49:33) “Linkedin Made Investors in Silicon Valley Accessible”(49:55) “Communication, Accessibility, Relationship building, and Information sharing make social media super powerful.”(55:40) “Take your time and do your due diligence on investors to understand whether their values are aligned with yours and whether you see that 10-15 years partnership happening.”(59:30) “We are flexible in the way we collaborate with founders. It can be a more passive approach, or for first-time founders more hands-on”(01:09:00) “When it comes to dilution, we rather have a smaller slice of a bigger pie, than a massive slice of a smaller pie” ⏰  Timestamps:(00:00) Unlocking the Secrets of Venture Capital: An Insider's View (03:15) Brave the Winter of England with Jeevan in December 2022 (05:44) The Journey to Becoming a Top Venture Capitalist in 2023 (11:00) Spotting the Next Big Tech Trend in 2023 (14:20) Empowering Female Entrepreneurs and VCs to Create Change (20:00) Breaking Barriers: What it Takes to Attract More Women in Tech VC (23:00) The Power of Warm Referrals and How VCs Evaluate a Pitch deck (26:00) Timing is Everything: When is the Right Moment to Approach a VC? (30:30) A Day in the Life of a Busy Venture Capitalist (39:30) Decoding Job Titles in Venture Funds: What They Really Mean (44:15) The Human Side of Investing: Why Relationships are Key (46:15) 2 Vital Lessons for Founders from a VC's Perspective (48:55) The Rise of Social Media in the Startup Investment World 2023 (50:35) Podpower: The Importance of Podcasts in Building Relationships in 2023 (52:25) Jeevan's Must-Listen Podcast List for Entrepreneurs and Investors (56:50) Expectations Beyond Returns: What VCs Look for in Founders (01:04:30) The Investors' Role in Board Functions and Aligning Interests (01:09:50) Finding the Perfect Match: Product/Market Fit (01:13:50) Jeevan's Most Exciting Deal: Behind the Scenes (01:16:25) The Art of Closing a Deal: A VC's Perspective (01:17:55) The Challenges of Closing a Deal and the Path to Success (01:20:45) Predicting the Future of VCs: 2023 and Beyond (01:25:00) The Final Word: Jeevan's Advice for Entrepreneurs and Investors Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link
Are you ready for the grand finale of our Year in Review Recording? The final episode of 2022 is here, and it's one for the books! We've explored the cutting-edge innovations and technologies shaping the future of the biotech industry with some of the most brilliant minds in the field. From Kurt Höller of EIT Health, to Albert Missbichler from Fianostics, Caroline Heil from the new meat company, Mauricio Agudelo and Lina Toro from Bialtec, Kimberly Cornfield from the UCL, Collin Ewald from ETH Zurich, and Guido Gualdoni from G.ST Antiviral, we've had some truly enlightening conversations. But we saved the best for last! Get ready for an exclusive interview with Dr. Thomas Schubert, CEO of 2bind, a provider of biophysical outsourcing solutions that is revolutionizing the way we study molecular interactions and protein stability. Don't miss out on this one-of-a-kind episode. Tune in now! This cutting-edge biotech company is revolutionizing how we study molecular interactions and protein stability. They're doing it with a track record of over 1400 successfully completed tasks in research projects with over 350 customers in the last 11 years.In this episode, you'll get an inside look at the driving force behind 2bind and the expert knowledge that sets them apart in the biophysics field. From breakthrough moments to industry trends, you'll gain a deeper understanding of the future of biotech and the role that companies like 2bind will play in shaping it.But that's not all! You'll also hear from Dr. Schubert about the company's partnerships with leading device producers and how they navigate the digital world to stay ahead of the curve. Plus, you'll get insight into the supply chain challenges that 2bind faced in the last years and how they overcame them.Don't miss out on this opportunity to learn from the best in the business! Tune in to our latest podcast episode and join the conversation on the future of biotech.Trust us; this episode is a must-listen for anyone in the biotech industry or anyone passionate about innovation and the future of medicine. It's packed with valuable insights and information you won't miss.💡 LINKS TO MORE CONTENT.If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Check out our partners: https://linktr.ee/lsg2Watch on YoutubeThomas SchubertChristian Soschner⏰  Timestamps:00:00) Introduction(02:00) Unveiling the mastermind behind 2bind, Dr. Thomas Schubert (04:05) Insider tips for starting your own biotech company(07:36) A glimpse into the future: 2022 for 2bind's CEO (10:40) Navigating the digital world: Pros and cons of technology in biotech (14:16) Overcoming obstacles: A look at 2bind's supply chain challenges (18:21) Game-changing developments in biophysics for 2022 (19:53) What's next for the After Hours Entrepreneur: Your Guide to Profitable, 6-Figure YearsQuit your job. Make more money.Listen on: Apple Podcasts   SpotifySupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link
On this episode of "Year in Review Recording," we speak with Guido Gualdoni, Co-Founder, and CEO of G.ST Antivirals, a clinical-stage biotech company revolutionizing how we treat viral infections of the respiratory tract. Guido shares the science behind G.ST Antivirals' innovative host cell-based strategy to develop broad-spectrum antivirals and how it completely eliminates viral reproduction without the risk of resistance development. He also delves into the public funding and startup ecosystem in Vienna, Austria, which has been instrumental in the company's success. He also talks about the future plans for G.ST Antivirals and the deep scientific tech valley in Central Europe. This episode is a must-listen for anyone interested in the latest advancements in biotech and the companies leading the way in treating viral infections. 💡 LINKS TO MORE CONTENT.If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Please support this show by checking out the companies that make it possible: https://linktr.ee/lsg2Watch on YoutubeGuido GualdoniChristian Soschner⏰  Timestamps:(00:00) Welcome to the Episode: Exploring the Public Funding and Eco-System in Vienna, Austria(02:35) Meet Guido Gualdoni, CEO of G.ST Antiviral(04:00) Discovering the StartUp Labs, Vienna Business Agency, AWS, FFG, Austrian Business Agency, LISA Vienna and their role in supporting startups(07:35) Exploring the Scientific Deep Tech Valley in Central Europe: Munich, Vienna, Zurich, Prague(10:15) G.ST Antiviral's 2022 Outlook(11:22) Uncovering the Innovative Technology Behind G.ST Antiviral(14:30) Guido's Biggest Takeaways from 2022(16:15) Why Optimism Bias Can be a Challenge for Entrepreneurs(18:15) Comparing the Scientific and Entrepreneurial Mindsets(24:00) The Surprising Companies that Succeeded During Economic Downturns(25:00) Examining the Latest Trends in Antiinfectious Diseases(27:45) Charting the Growth of G.ST Antiviral in 2023After Hours Entrepreneur: Your Guide to Profitable, 6-Figure YearsQuit your job. Make more money.Listen on: Apple Podcasts   SpotifySupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link
Introducing "The Year in Review Recordings", a series where we reflect on the past year and look forward to the coming one. Hosted by Christian Soschner, this podcast brings you expert speakers from previous episodes and partners of the podcast to give you an in-depth analysis of the latest advancements in their fields and an outlook for the future. This is the 6th conversation in the series.In this episode, we have Dr. Collin Y. Ewald, founder and president of the Swiss Society for Aging Research and head of the Extracellular Matrix Regeneration Laboratory at the Department of Health Sciences and Technology. Dr. Ewald has a longstanding interest in the molecular biology of healthy aging and age-related pathologies. He is a leading expert in the field and has received multiple awards, including NYAS Future Entrepreneur, recognized by the New York Academy of Sciences. He is named among the top 1000 Longevity Leaders worldwide and the top 15 Longevity Influencers in Switzerland.We'll be discussing Dr. Ewald's recent work on the expression of extracellular matrix genes during aging, the role of the mTOR kinase in aging, and the challenges of bridging gaps in longevity research between scientific disciplines and languages. We'll also be discussing the Ewald Lab's recent work on the expression of extracellular matrix genes during aging, the role of the mTOR kinase in aging, and the challenges of bridging gaps in longevity research between scientific disciplines and languages.This episode also includes topics such as Longevity Research and Horizon Europe, How to Bridge the Gap in Horizon Programs between scientific disciplines and different languages, The 9 Hallmarks of Ageing, Solving the Clinical Trial Challenges in Longevity Research, Food Supplements for Longevity in 2023, Collin Ewald’s Spin Out Company, The 10 Simple Rules to Start a Successful Spin-Off Company, 2023 in Longevity Research – Upcoming Trends.Don't miss out on this episode of "The Year in Review Recordings," where we dive into the world of longevity research with Dr. Collin Y. Ewald and stay informed about the latest advancements in the field.💡 LINKS TO MORE CONTENT.If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Please support this show by checking out the companies that make it possible: https://linktr.ee/lsg2Watch on YoutubeCollin EwaldChristian Soschner⏰  Timestamps:(00:00) Intro (03:00) Welcome Note Collin Ewald(04:25) Longevity Highlights in 2022 in the Ewald Lab, ETH Zurich(07:08) Published Results of a 9 year study to understand the mTOR Kinase and its role in ageing better(08:52) Longevity Research and Horizon Europe(11:08) How to Bridge the Gap in Horizon Programs between scientific disciplines and different languages?(14:35) Highlights in the Longevity Research Area in 2022(17:08) The 9 After Hours Entrepreneur: Your Guide to Profitable, 6-Figure YearsQuit your job. Make more money.Listen on: Apple Podcasts   SpotifySupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link
Are you ready to unlock the secrets of securing funding and achieving impact in the world of European research and innovation? In this episode of our podcast, we explore the latest trends and developments in research and innovation with Kimberly Cornfield, Assistant Director (Project Development & Management) and Head of European Research and Innovation at University College London (UCL). UCL is one of the top-performing universities under the EU's Horizon 2020 program and has secured around €400 million over the last seven years to support its research and innovation activities.Kimberly and her team connect scientists and businesses around EU collaborative funding opportunities and offer a suite of support services to improve the chances of success in obtaining funding and achieving impact objectives. We'll discuss the current state of European research funding, the challenges and benefits of virtual meetings, and the future for research and innovation.💡 LINKS TO MORE CONTENT.If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Please support this show by checking out the companies that make it possible: https://linktr.ee/lsg2Watch on YoutubeKimberly CornfieldChristian Soschner⏰  Timestamps:(00:00) Introduction Kimberly Cornfield, UCL, and Horizon Europe(05:12) Highlights UCL and Horizon Europe Grant Funding in 2022(07:20) Advantages and Challenges – Virtual or Real Life Meetings?(09:00) Benefits of the Virtual World for UCL Research Projects(10:21) Horizon Europe(14:28) Future Trends in Research(17:28) The Rise of Social Sciences(19:28) The Relevance of Fairy Tales for Research(23:05) The Horizon Europe Work Programme for 2023(26:00) Wishes for 2023After Hours Entrepreneur: Your Guide to Profitable, 6-Figure YearsQuit your job. Make more money.Listen on: Apple Podcasts   SpotifySupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link
Are you ready to discover the secrets of precision nutrition and AI in the animal protein industry? Join us as we speak with the founders of BIALTEC, Mauricio Agudelo and Lina Maria Toro, to gain exclusive insights on the industry's challenges and opportunities. From tackling logistics and inflation to understanding the future of animal nutrition, this episode is packed with game-changing information you won't want to miss. Tune in now and get ready to be inspired by the innovation and vision of BIALTEC.💡 LINKS TO MORE CONTENT.If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Please support this show by checking out the companies that make it possible: https://linktr.ee/lsg2Watch on YoutubeChristian SoschnerMauricio AgudeloLina Toro⏰  Timestamps:(00:00) Introduction Lina Toro and Mauricio Agudelo, Founders at Bialtec(05:54) Creating Microbiomes for Animals(09:13) Big Challenges in 2022 for Bialtec – Logistics and Inflation(11:38) How did Lina Toro, CFO of Bialtec, deal with the global environment (13:31) Perceived Inflation Rate in the Bialtec Eco-System(14:19) Energy Prices in South America in 2022(16:40) Bialtec’s Activities in Europe(20:22) 3 Improvements for Founding a Company in Europe(25:28) Trends in the Animal Nutrition Industry in 2023After Hours Entrepreneur: Your Guide to Profitable, 6-Figure YearsQuit your job. Make more money.Listen on: Apple Podcasts   SpotifySupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link
Are we on the brink of a technological revolution that will render content creators obsolete? Join us as we explore the rise of ChatGPT and its potential impact on the creative industry. From its capabilities as a natural language processing tool to its comparison to Bitcoin in the financial world, we'll discuss the pros and cons of this game-changing technology. Tune in to discover the truth behind the hype and what it means for content creators like you.Youtube Video⏰ Timestamps:(00:00) What Novel Technology Means(03:30) What is ChatGPT?(04:50) What Does ChatGPT Mean for the Creative Industry - ChatGPT Usecases(06:45) How ChatGPT can help in the Brainstorming/ideation Phase(10:00) Utilizing the Research Phase with ChatGPT(12:15) How can ChatGPT Help with Producing a Piece of Content?(15:38) ChatGPT as a Team for Rewriting, Editing, and Repurposing Content to Make it Native to Different Platforms(18:00) Ethical and Legal Questions🔗 Podcastlinks:EpisodesFull Youtube PlaylistFull Clips PlaylistPartner LinksChristian SoschnerSupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link
Celebrate with us as we reach our 100th podcast episode! Join us as we look back on the past three years and revisit the 5 most downloaded episodes. From exploring the use of blockchain technology in the energy sector, to gaining valuable insights into the daily life of a VC and learning how to succeed in the competitive world of drug development, this special episode has something for everyone. Thank you for being a part of our journey and for supporting our mission to promote scientific entrepreneurs and shape a bright future for humanity. Don't miss out on this celebratory milestone episode!💡 LINKS TO MORE CONTENT.If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Please support this show by checking out the companies that make it possible: https://linktr.ee/lsg2⏰  Timestamps:(00:00) Episode 100(03:15) #5: Sascha Bucher – Forty51 Ventures(14:35) #4: Ana Trbovich – Grid Singularity(28:22) #3: Jonathan Sporn – Gilgamesh Pharmaceutical(44:35) #2: Heike Schön – Lumis International(01:04:00) #1: Alexander Belcredi – Biontech Austria(01:18:00) Outlook for 2023After Hours Entrepreneur: Your Guide to Profitable, 6-Figure YearsQuit your job. Make more money.Listen on: Apple Podcasts   Spotify The Immigration GuyThe Immigration Guy combines Kyle Farmer's expertise and innovation on all topics...Listen on: Apple Podcasts   SpotifySupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link
Welcome to the third part of "This was 2022 - A Year in Review," a special edition of the Beginner's Mind Podcast. I'm your host Christian Soschner and I'm excited to be joined by Albert Missbichler, a business angel with over thirty years of experience in biochemistry and clinical diagnostics. In this episode, we'll be discussing the highlights of 2022, the differences between scientific B2B and B2C, and the challenges of translating science into simple words. We'll also be exploring the lifestyle habits and health literacy of Gen Z, as well as the crucial habits for longevity. Finally, we'll be discussing the changes in the post-pandemic conference industry and the big trends to look out for in 2023 in diagnostics. Stick around for all of this and more with Albert Missbichler on the Beginner's Mind Podcast.💡 LINKS TO MORE CONTENT.If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Please support this show by checking out the companies that make it possible: https://linktr.ee/lsg2Watch on Youtube⏰  Timestamps:(01:23) Prediction Caroline Heil for 2023(02:06) Introduction Albert Missbichler and Fianostics(03:00) Highlights Albert Missbichler in 2022 – from B2B to B2C(04:40) The  Biggest Differences between Scientific B2B and B2C(07:00) Challenges of Translating Science into Simple Words(11:30) Lifestyle Habits and Health Literacy of Gen Z(17:45) Crucial Habits for Longevity(21:15) Postpandemic Meeting Habits – What changes, what remains(25:20) Changes in the Post-Pandemic Conference Industry (28:00) Big Trends in 2023 in Diagnostics(32:00) Inoolab and FluoboltAfter Hours Entrepreneur: Your Guide to Profitable, 6-Figure YearsQuit your job. Make more money.Listen on: Apple Podcasts   SpotifySupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link
Welcome to the first days of 2023! As we bid farewell to the past year, I wanted to take a moment to appreciate all the amazing conversations on my podcast over the past 12 months. From global crises to personal triumphs and failures, 2022 has been a year like no other.I covered various topics on the show, from venture capital to clinical development, psychedelics, virtual reality, and biophysics. In honor of these incredible episodes, I have decided to end the year with a compilation of the best moments from the previous 12 months.It was difficult for me to choose just five standout conversations from the many I've had, so I enlisted the help of ChatGPT to generate five numbers between 60 and 97 randomly. These five episodes are the ones I've chosen to highlight.But as we enter the new year, it’s also a time to look ahead and plan for what lies ahead. In the words of CS Lewis, "The future is something which everyone reaches at the rate of sixty minutes an hour, whatever he does, whoever he is." So grab your holiday cheer, join me as I reflect on the past year’s highlights, and look ahead to what’s in store in the new year. The clock is ticking, and the future is waiting. So, don't miss out and tune in to this YouTube video for all the exciting details!💡 LINKS TO MORE CONTENT.If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Please support this show by checking out the companies that make it possible: https://linktr.ee/lsg2Watch on Youtube⏰  Timestamps:(00:00) Welcome 2023(03:02) Episode 70: Bruno Montanari - Seroba Life Science - The Role of Venture Capital(13:00) Episode 71: Heike Schön - Lumis International - How to Rescue Clinical Trials(24:45) Episode 79: Jonathan Sporn - Gilgamesh Pharmaceuticals - Psychedelic Drugs(39:21) Episode 94: Adrian Brodesser - Somareality - Digital Diagnostics with Virtual Reality(54:22) Episode 93: Thomas Schubert - 2bind - Biophysics(01:09:00) Beginner’s Mind Podcast: Outlook to 2023After Hours Entrepreneur: Your Guide to Profitable, 6-Figure YearsQuit your job. Make more money.Listen on: Apple Podcasts   Spotify The Immigration GuyThe Immigration Guy combines Kyle Farmer's expertise and innovation on all topics...Listen on: Apple Podcasts   SpotifyThe LSG2G Partners Experts in Life ScienceSupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link
Welcome to the second part of "This was 2022 - A Year in Review," a special edition of the Beginner’s Mind Podcast as we close the year and look ahead to 2023. I'm your host Christian Soschner, and I'm excited to be joined by Caroline Heil, CEO of The New Meat Company.Caroline is a seasoned investor passionate about revolutionizing the food industry sustainably and healthily. She has worked for EY as a lawyer. She has experience advising clients on corporate aspects of M&A transactions and VC investments, with a focus on the alternative protein and meat market, food security, and sustainability.The New Meat Company is a purpose-driven impact investment company based in Berlin that invests in game-changing companies and founders disrupting the traditional meat industry with sustainable, nutritious, and tasty alternatives. They have a buy-and-build strategy, consolidating established pioneers and emerging game-changers in the alternative meat space and partnering with innovative individuals who prioritize animal welfare and reducing the ecological footprint of meat production.In this episode, Caroline will share her insights on the key trends in the food industry, the importance of proper nutrition for long-term health, and her advice for startups and scaleups seeking investment. She'll also give us a preview of what to expect in 2023 and the ideal investment opportunity for The New Meat Company.So sit back, relax, and get ready to learn from one of the top investors in the food industry as we close out the year and look ahead to the future.We have a full schedule of speakers lined up, including Kurt Höller from EIT Health, Albert Missbichler, a business angel, Lina Toro and Mauricio Agudelo from Bialtec, Kimberly Cornfield from UCL, Collin Ewald from ETH Zurich, Guido Gualdoni from G.ST Antivirals, and Thomas Schubert from 2bind.We'll be tackling questions such as:•What excited you the most in 2022?•What should change in 2023?I hope you enjoy the episode from this exciting year-in-review event.💡 LINKS TO MY OTHER CHANNELS:If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Watch in Youtube⏰  Timestamps:(00:00) Introduction Caroline Heil and the New Meat Company(05:00) Why Eating Habits are Key to a Long and Healthy Life(05:30) Getting the Nutrition Habits Right in Society has the potential to reduce healthcare expenses by 90%(08:45) The Optimal Nutrition Habits for 2023(11:50) Highlights of 2022 – Caroline Heil and The New Meat Company(12:50) The Investment Approach of The New Meat Company(14:25) Big Trends in the Food Industry in 2022(17:00) Availability of Capital in the Food Industry For Startups and Scaleups(19:30) Investment Insights in the Old Economy(20:45) Investors Advice for Startups(23:00) The Ideal Investment Opportunity for TNMC(28:15) The Big Trends in the Food Industry for 2023After Hours Entrepreneur: Your Guide to Profitable, 6-Figure YearsQuit your job. Make more money.Listen on: Apple Podcasts   SpotifyThe LSG2G Partners Experts in Life ScienceSupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link
Hey everyone, this is Christian Soschner from the Beginners Mind Podcast I just wanted to take a quick moment to say thank you for following the podcast channel in 2022. Your support and engagement mean the world to me, and I am truly grateful for each and every one of you.As we head into the new year, I want to assure you that I will continue to bring you valuable content in health, healthcare, pharma, artificial intelligence, entrepreneurship, and investing. These topics are close to my heart, and I am dedicated to sharing the latest research, insights, and trends with you.But it's not just about the content but the connection. I am committed to building a community of like-minded individuals who are passionate about these topics and are eager to learn and grow together.So let's make the most of this new year. Let's decide today who we will become, what we will give, and how we will live. And let's do it with purpose, passion, and a desire to impact the world around us positively.Thank you again for your support. I look forward to continuing to bring you valuable content and being a part of this amazing community in 2023 and beyond. And before you leave for the new year's celebrations, please consider hitting the like button, leaving a comment, and following our channel. Your support helps me grow my podcast and allows me to reach more people who can benefit from my content. And if you have a moment, please consider leaving a 5-star review on Apple Podcasts and Spotify – it really helps me out. Thank you again and have a happy new year!Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link
Welcome to the year-in-review podcast for 2022! As the year comes to a close, I am excited to reflect on the successes and learnings from the past 12 months and look ahead to what 2023 has in store.I have an incredible lineup of speakers from 90 previous podcast episodes; the event was live-streamed before Christmas on LinkedIn, YouTube, Twitter, and Facebook, so listeners could tune in from anywhere. To conclude the year and start into 2023, each speaker will be featured in their podcast episode.As a starter, I am thrilled to have Kurt Höller from EIT Health joining. Kurt will share his most memorable moments from 2022, his biggest successes and learnings, and his expectations for 2023. We'll also be discussing EIT Health and getting an overview of the LSG2G community.Kurt Höller is the Director of Business Creation at EIT Health, a leading healthcare initiative supporting over 750 startups and providing access to key industry players. He has a wealth of experience in healthcare, including founding and directing several companies, and a strong background in research, with a focus on health innovation.We have a full schedule of speakers lined up, including Caroline E. Heil from The New Meat Company, Albert Missbichler, a business angel, Lina Toro and Mauricio Agudelo from Bialtec, Kimberly Cornfield from UCL, Collin Ewald from ETH Zurich, Guido Gualdoni from G.ST Antivirals, and Thomas Schubert from 2bind.We'll be tackling questions such as:•What excited you the most in 2022?•What should change in 2023?I hope you enjoy the episode from this exciting year-in-review event. 💡 LINKS TO MY OTHER CHANNELS:If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Watch in Youtube⏰  Timestamps:(00:00) Intro to Year in Review, Kurt Höller, And EIT Health(03:00) Chat GPT as a helper to find questions for the podcast recording(04:30) Kurt shares his personal highlights from 2022(07:30) EIT Health in 2022(08:30) Events after the pandemic – From EIT Health Summit to Bits and Pretzels(11:00) Bits & Pretzels – The European Woodstock for Startup Entrepreneurs(12:55) Bavaria, White Sausages and Beer Habits(14:30) Kurt’s New Role as Managing Director of InvestHealth(17:30) The Venture Capital Situation in Europe in 2022(21:28) Healthtech Investment Trends in the Coming Years(23:30) Europe Becomes a Single Market for Health Apps(34:00) Estonia – Leader in Digital Adoption in Many CategoriesAfter Hours Entrepreneur: Your Guide to Profitable, 6-Figure YearsQuit your job. Make more money.Listen on: Apple Podcasts   SpotifySupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link
In this episode, I unlock the untold stories behind PayPal's meteoric rise and the entrepreneurs who made it possible.The author Jimmy Soni explores the captivating story of PayPal and the entrepreneurs who helped shape Silicon Valley. From Elon Musk to Peter Thiel and many others whose stories have never been told, hear about the scrappy online payments start-up that faced fierce competition and internal strife on its journey to becoming one of the world's foremost companies. ⭐ EPISODE Links:Jimmy SoniPlease support this show by checking out the companies that make it possible.Youtube📚 Book Mentions:Jimmy Soni, The Founders Sebastian Mallaby, The Power Law 🗣️ We are talking about: • The Inspiration for writing this book• Dissecting Jimmy’s Writing Process• The Origin Story of the Paypal-Mafia• The Role of Chess and The Secret Code Hidden in the Book• Storytelling Lesson for Entrepreneurs• And much, much more📖 Memorable quotes:(20:55) “I do my books while working full-time. All my books are morning and weekend exercises.”(24:46) “I interviewed almost 300 people for this book.”(35:45) One executive said: "Calling Paypal a Mafia is an insult to the Mafia. They are far more organized than we were back then."(51:04) “David Sacks said: … as easy as email”(56:50) “The most important question for business owners: Who in the team is obsessed with how the end-user thinks and uses the product?”(01:34:30) People forget that startups are stories.⏰  Timestamps:(00:00) Intro from the Recording the Day after Thanksgiving 2022(05:55) What inspired Jimmy Soni to write the Founders?(10:00) The Entrepreneurs who Shaped Silicon Valley(16:15) Peter Thiel: How to Learn the Right Lessons in Entrepreneurship(19:24) How long does it take to write a book like the Founders?(22:15) Writing Books as a Side Hustle to writing as a profession (23:00) Exploring the Challenges of Writing Biographies of Historical and Modern Figures(25:23) Uncovering the Truth: Strategies for Sorting Through Conflicting Narratives in Interviews(27:30) The Writing Scorecard: Number of Words per Day(28:40) Uncovering the Journey from Idea to Publication: A Look at Jimmy Soni's Writing Process(30:30) Max Levchin and Tetris(32:17) The Origin Story of the Term “Paypal-Mafia”(39:00) From Beaming Money to Venmo: 20 Years of Product Development(43:00) David Sacks Halts the Progress of Groundbreaking Beaming Technology and the Birth of Digital Payment Solutions(49:40) How Paypal Found Product Market Fit(53:42) The Switch challenges from finding a solution to focusing on scaling up the solution.(58:00) The Role Chess Plays in Jimmy Soni’s Book and Paypal’s History(01:02:27) The Secret Code Hidden in the Book: Crack the Code and Get a Signed Copy(01:03:00) The Bad Bishop Situation(01:06:00) Bitcoin, the Paypal Mafia, and the New World Currency Tagline(01:15:00) Elon Musk's challenges in finding the right decisionsAfter Hours Entrepreneur: Your Guide to Profitable, 6-Figure YearsQuit your job. Make more money.Listen on: Apple Podcasts   SpotifySupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link
As the holiday season has started, I wanted to take a moment to wish you all a very Merry Christmas. I hope this time of year brings you joy, peace, and happiness.Remember to stay positive and hopeful as we look ahead to the new year. 2023 is a new opportunity to set goals, make positive changes, and achieve our dreams.I hope you can spend this holiday season with loved ones, surrounded by warmth and cheer. May your Christmas be filled with love, laughter, and everything that brings you joy.Merry Christmas and Happy Holidays to you all!Youtube VideoSupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link
Which Role do Wearables like Virtual Reality Devices play in the Future of Diagnostics?In this episode, I am excited to talk with Adrian Brodesser, CEO of Somareality, to explore the latest technological developments and their impact on society.Adrian will be joining us to discuss the use of VR in diagnosing neurological diseases and how these devices are revolutionizing the way we approach healthcare. From Alzheimer's to Parkinson's, virtual reality is providing doctors with new tools to understand and treat these complex conditions.So join us as we delve into the world of VR and healthcare with Adrian Brodesser and learn how this technology is changing the game for the diagnosis and treatment of neurological diseases.⭐ We discuss topics like:•How to find product market fit for VR•Core Business of Somareality•VR Use Cases in Healthcare and Sports•Use Cases for VR-based Diagnostics•Challenges of Entrepreneurship⭐ EPISODE Links:Today’s speaker is Adrian Brodesser, CEO of Somareality Youtube📖 Memorable Quotes(10:00) "Entrepreneurship is really hard."(48:10) "With Eyetracking, we can measure if the person is overwhelmed with parts of the process."(50:30) "The AI helps people to understand where they are struggling and which steps they should take from here on."(01:00:09) "A lot of great insights into the early-stage dedication of diseases can be derived from eye-tracking."(01:10:30) "Technology-based Diagnostics will be vastly available in the future"(01:32:00) "3 pieces of Advice for New Entrepreneurs"📚 Book Mentions:(17:30) Jimmy Soni The Founders⏰ Timestamps(00:00) Kick Off(06:40) Entrepreneurship in 2022(12:40) The Art of saying no(20:30) The Magic of Finding Product Market Fit(24:05) Selling – The Most Important Skill for Startups(28:34) How to Sell to the Healthcare Industry(32:15) Core Business of Somareality – Usecases for VR(41:00) How VR helps to understand the User Better(44:12) Commercial Potential of VR – Intuitive Surgical, Lufthansa and Somareality(52:15) Use Cases in Healthcare and Sports for Attention Tracking(56:00) Digital Diagnostics with VR(59:15) The Research Behind Eyetracking with VR for Diagnostics (01:02:23) Aware Virtual Reality Systems – The Future of VR(01:10:26) The Long-Term Future of VR-based Diagnostics(01:16:25) Near Future Use Cases for VR-based Diagnostics(01:19:00) Elevator Pitch for VR-based Diagnostics(01:22:35) Objective Pain Measurement with VR(01:29:00) Fundraising(01:30:50) Custom Solutions for the B2B Environment(01:31:00) 3 Points for Entrepreneurs who start a businessLinks: New study will look at how virtual reality can help diagnose dementia | Brain Sciences - UCL – University College London[Virtual reality and dementia] - PubMed (nih.gov)After Hours Entrepreneur: Your Guide to Profitable, 6-Figure YearsQuit your job. Make more money.Listen on: Apple Podcasts   SpotifySupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link
What is the Role of Biophysics in Drug Development and Drug Discovery?In this episode, I speak with Dr. Thomas Schubert, CEO of 2bind, a provider of biophysical outsourcing solutions for the pharmaceutical. Dr. Schubert discusses the role of biophysics in drug development and the importance of outsourcing in the pharmaceutical industry.⭐ In this episode, we talk about:The Role of Biophysics in Drug DevelopmentThe Role of Biophysics in Antibody ResearchSuccess Stories in BiophysicsThe Development of the Life Science Industry in Europe from the Biophysicist's PerspectiveFuture Trends in Drug Discovery and Drug Development⭐ EPISODE Links:Today’s speaker is Thomas Schubert, CEO of 2bindDr. Thomas Schubert received his Ph.D. in Biochemistry in 2012 from the University of Regensburg. Dr. Schubert joined 2bind in 2012 and was called for the CEO position in 2013. Dr. Schubert received the degree Betriebswirt (business economist) in 2014.Youtube📚 Book mentions in the episode:The Power LawDas Netzwerkunternehmen📖 Memorable Quotes:(04:30) “At 2bind, we are active with Webinars to educate people.”(08:15) “Biophysics is using physical measurement and interpretation to understand Biology"(24:40) “Many different changes in the environment of drug discovery occurred, and all of them pushed Biophysics.”(52:30) “Always employ people that are better than you”(01:29:27) “Biophysics will play a big role in Drug Discovery in 10 years”⏰ Timestamps:(00:00) Intro (02:00) Recap Bio Europe in Leipzig and Bio International in San Diego after the Pandemic Break(04:15) Integrating Social Media into Business Strategies(07:30) The Role of Biophysics in Drug Development(11:00) Background Thomas Schubert and 2bind(20:00) How has the Role of Biophysics in Drug Development evolved over the last 10 years(26:30) The Role of Biophysics in Antibody Research & Development(29:30) Biophysics and ADCs(33:00) 2bind’s position in the pharmaceutical value chain(38:30) How to combine scientific and development mindsets in the industry(43:30) Competition and Expertise in the Biophysics World(46:15) Technologies used in biophysical research projects(52:19) Challenges for Entrepreneurs Running a Deep Tech Service Business(56:30) Success Story #1: Lead Identification with 2bind(58:30) Success Story #2: Formulation Study with an HIV Vaccine Candidate(01:03:00) The Big Challenges for Pharma in this Century – Antibiotics, HIV, Cancer(01:10:00) The Development of the Life Science Industry in Europe (01:17:00) Outsourcing – when is it the best solution for companies?(01:24:00) Future Trends in Drug Discovery and Drug Development from the Biophysicist’s Perspective(01:36:00) Epigenetics, AI, and Chess(01:43:00) How to Connect with Thomas SchubertAfter Hours Entrepreneur: Your Guide to Profitable, 6-Figure YearsQuit your job. Make more money.Listen on: Apple Podcasts   SpotifySupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link
How did Venture Capital evolve? When did it start? Get the answers right here in the book The Power Law by Sebastian Mallaby.⭐ In this episode, we talk about:• Storytelling Methods and a Writers Work Process• What is Venture Capital – From the Writers Perspective• How Did Silicon Valley Evolve into the Center of the Innovation World?• The 3 Most Crucial Moments in the Development of Venture Capital• The Future of the European Tech Eco-System• And much, much more⭐ EPISODE Links:Today’s speaker is Sebastian Mallaby. Youtube📚 Book mentions in the episode:The Power Law📖 Memorable Quotes:(09:39) “In a Content Creators Economy where a lot of people spend a lot of time creating, it is worthwhile to spend 5 years writing a book”(12:46) “Do Venture Capitalists create innovation, or do they just show up for it?”(18:51) “Europe is fundamentally full of great engineers. It is a great market. Why wouldn’t it rival the United States if it got the right Venture Capital to take the risk.”(23:10) “The European culture is not as risk-friendly as the US. But it’s changing fast.”(27:45) “Genentech was the beginning of staged investments.”⏰ Timestamps:(00:00) Speaker and Book Intro(02.25) Storytelling Methods and a Writer's Work Process(08:00) Development of the Methodology – From Nelson Mandela to Venture Capital(10:33) What is Venture Capital – From the Writer's Perspective(16:00) How Did Silicon Valley Evolve into the Center of the Innovation World?(19:39) Why Cover the Majority of the Stories about the US and Asia and very few stories about Europe?(27:41) The 3 Most Crucial Moments in the Development of Venture Capital(29:45) How Sequoia got into the hot tub with Atari(32:00) Softbank – Everybody Needs a 100 Million(39:00) Alibaba(43:45) The Future of Venture Capital(47:15) The Future of the European Tech Eco-System⭐ Please support this podcast by checking out our partners: https://linktr.ee/lsg2gSebastian Mallaby is the Paul A. Volcker senior fellow for international economics at the Council on Foreign Relations (CFR). An experienced journalist and public speaker, Mallaby contributes to a variety of publications, including Foreign Affairs, the Atlantic, the Washington Post, and the Financial Times, where he spent two years as a contributing editor. He is the author of five books, most recently The Power Law: Venture Capital and the Making of the New Future.After Hours Entrepreneur: Your Guide to Profitable, 6-Figure YearsQuit your job. Make more money.Listen on: Apple Podcasts   SpotifyThe LSG2G Partners Experts in Life ScienceSupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link
What is the Role of Artificial Intelligence in Drug Development and Drug Discovery?⭐ In this episode, we talk about:Deep Mind’s AlphafoldInvesting in Life Science companiesThe State of AI in Drug Development and Drug DiscoveryHow does GDPR limit the development of AI in Drug DiscoveryThe Human Genome and AIToday’s speaker is Marco Schmidt, CSO of Biotx.aiMarco had an exceptional academic career. He won the best PhD of the year award in Chemistry in his home country Germany and then went on to do a Post-Doc at the University of Cambridge.⭐ EPISODE Links:Marco Schmidt on Linkedin Youtube 📖 Quotes:(24:45) “Eroom's law is the observation that drug discovery is becoming slower and more expensive over time”(56:05) “We need more data”(58:13) “Biobanks provide the infrastructure that we really need in the future”(01:16:39) “Prediction Models of Type 2 Diabetes Have 99% Accuracy”(01:17:50) “There is no longevity gene. There are shortevity genes.”(01:53:45) “We are living in fantastic times” ⏰ Timestamps:(00:00) Kick Off and Intro(06:15) Deep Mind’s Alphafold(07:06) Background to Marco Schmidt and Biotx.ai (12:00) Business Model in AI for Drug Development – from Service Provider to Developer(13:15) Basic Definition of Drug Discovery and Drug Development for the Listeners of the Episode(17:20) For Retail Investors who have an eye on investing in public drug development companies: What is a Ligand?(20:09) Why is Drug Discovery Expensive and Lengthy?(23:30) Success and Failure Rate in Drug Development(24:30) What is erooms Law?(27:25) What is the right place for innovation? Startups or Big Corporations?(30:00) The Value Chain in the Pharma Industry – From Research to Marketed Products.(34:00) Investing in Life Science Companies(50:15) Why is Artificial Intelligence an Attractive Area?Speaker and Company(55:00) The State of AI in Drug Development and Drug Discovery – What is Science and What is Still Fiction.(58:00) Accessibility of Data – Is this the bottleneck in Artificial Intelligence Based Drug Discovery?(01:10:00) What would change in Drug Development if scientists could access healthy population data?(01:12:30) Prediction Models for Cancer, Alzheimer, and other diseases(01:16:00) Understanding the progression of diseases and the role lifestyle plays in AI(01:19:00) How does GDPR limit the development of AI in Drug Discovery(01:24:00) Data Curation in AI(01:28:45) Is Capital a Limiting Factor?(01:34:26) The Human Genome and AI(01:40:00) Is it possible to simulate the entire drug development process from lab to market?(01:46:00) Service Offerings of biotx.ai(01:51:30) How can AI help select the right patients?(01:59:00) Synthetic clinical trials(02:01:00) The Role of Excel in Machine Learning📚 Book Mentions:Drug Discovery and Drug DevelopmentThe Power Law After Hours Entrepreneur: Your Guide to Profitable, 6-Figure YearsQuit your job. Make more money.Listen on: Apple Podcasts   SpotifySupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link
Do you understand the dynamics of the stock market? Here is an episode with Brian Feroldi, Writer at the Motley Fool, on his new book “Why the stock market goes up?”We are talking about⭐ The Global Problem With Financial Literacy⭐ Why Did Brian Feroldi Write a Book About Investing for Beginners?⭐ Why Does the Market Crash from Time to Time?⭐ Cost Averaging and Index Investing – A Powerful Tool for People who don’t have time to diligently follow the market⭐ What was Brian’s Biggest Investment Mistake?A basic understanding of the stock market is mandatory for every deep tech entrepreneur, business angel, and venture capitalist. A stock market is a place where companies can get more liquidity for scaling their business and provides an exit for early investors.Brian Feroldi describes the mechanics of the stock market in his latest book: Why does the stock market go up? I enjoyed his unique way of explaining complex economic situations in easy-to-understand layman’s terms.Brian Feroldi is a financial educator, YouTuber, and author. Since college, he has been intensely interested in money, personal finance, and investing.⭐ EPISODE Links:Brian Feroldi on YoutubeYoutube Video📖 Quotes:(05:31) "A lack of financial literacy is a global phenomenon"(14:50) "...it took me about 18 months to write it. ... I think we needed a book that explains in plain English what the stock market is - for beginners."(16:11) "If you look back on stock market history - it is very clear: Every ten years ... or so ... things go to hell!"(33:00) "Only Business Profits drive the Stock Market in any given direction"(43:53) "Investing in an Index Fund is totally fine for 99% of investors because they have no interest in reading SEC filings or doing research."(01:08:00) "Think Long-Term"⏰ Timestamps: (00:00) Introduction(01:52) Why Deep tech Entrepreneurs Need a Basic Understanding of the Stock Market.(04:00) Brian Feroldi's studio(05:17) The Problem With Financial Literacy(06:35) How Brian got Into Investing?(08:00) The Motley Fool (10:05) Why Did Brian Feroldi Write a Book About Investing for Beginners?(15:00) Reflecting on the Tech Market Correction in 2022 and Other Stock Market Crashes(19:19) The 2000 and 2008 Crash Experience(23:20) Why Does the Market Crash from Time to Time?(27:50) Crowd Mentality, Market Timing, and Contrarian Investing(32:55) The 3 Major Forces That Drive the Stock Market Up(36:55) Why Should People Invest When Fear, Uncertainty, And Doubt are on the Market?(39:32) What were your biggest questions when you started investing?(43:25) Warren Buffetts S&P500 ETF Strategy for People who don't have time for market research(45:23) Cost Averaging and Index Investing – A Powerful Tool for People who don't have time to diligently follow the Market(48:00) What is Compounding?(51:11) What is the Magnitude of Stock Market Fluctuations (55:05) Brian Feroldi's on Cathie Wood's Ark Innovation Fund(01:00:00) What was After Hours Entrepreneur: Your Guide to Profitable, 6-Figure YearsQuit your job. Make more money.Listen on: Apple Podcasts   SpotifySupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link
loading
Comments 
Download from Google Play
Download from App Store